Exagen Inc.XGNNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
-8.72
↓ 22% vs avg
Percentile
P17
Within normal range
Streak
3 yr
Consecutive declineContracting
Average
-7.15
Historical baseline
PeriodValueYoY Change
2025-8.72-28.6%
2024-6.78-492.7%
2023-1.14-261.9%
2022-0.32+93.6%
2021-4.95+50.5%
2020-10.00+71.0%
2019-34.43-1080.2%
2018-2.92-650.9%
2017-0.39+78.6%
2015-1.81-